Frequency ExchangeFRECF 8 Revenue per Share is $0.01 as of Mar. 2026. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 753 Medical Devices & Instruments companies, Frequency Exchange ranks worse than 69.46% on this metric.
Frequency Exchange's revenue per share for the
three
months ended in Mar. 2026 was $0.00.
Frequency Exchange's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01.
Warning Sign:
Frequency Exchange Corp revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Frequency Exchange was -50.00% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Frequency Exchange's Revenue per Share or its related term are showing as below:
FRECF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -5.3 Med: -5.3 Max: -5.3
Current: -5.3
During the past 6 years, Frequency Exchange's highest 3-Year average Revenue Per Share Growth Rate was -5.30% per year. The lowest was -5.30% per year. And the median was -5.30% per year.
FRECF's 3-Year Revenue Growth Rate is ranked worse than 69.46% of 753
companies
in the Medical Devices & Instruments industry
Industry Median: 3.8
vs FRECF: -5.30
Frequency Exchange (OTCPK:FRECF) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Frequency Exchange Revenue per Share Related Terms
Frequency Exchange Revenue per Share Historical Data
* Premium members only.
The historical data trend for Frequency Exchange's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRECF vs ABT, SYK, MDT: Revenue per Share Comparison
For the Medical Devices subindustry, Frequency Exchange's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's PS Ratio distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Frequency Exchange's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Exchange (FRECF) has a Revenue per Share of $0.01 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Frequency Exchange and its competitors. According to the industry distribution chart, Frequency Exchange ranks #523 out of 753 companies in the Medical Devices & Instruments industry, placing it in the top 69.5%.
Is Frequency Exchange's Revenue per Share too high?
Frequency Exchange's current Revenue per Share is $0.01. The Medical Devices & Instruments industry median Revenue per Share is 3.80. Frequency Exchange's value of $0.01 is 99.7% below this industry median. Based on the distribution chart, Frequency Exchange ranks #523 out of 753 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's Revenue per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #523 out of 753 companies for Revenue per Share. This places Frequency Exchange in the lower half of its industry. The industry median Revenue per Share is 3.80. Frequency Exchange's value of $0.01 is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.80, based on 753 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frequency Exchange's current Revenue per Share of $0.01 is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Frequency Exchange and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current Revenue per Share is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.24 — trading 202.8% above its estimated fair value. The current Revenue per Share is $0.01 and 99.7% below the Medical Devices & Instruments industry median of 3.80. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current Revenue per Share is $0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.24 is trading 202.8% above its estimated GF Value™ of $0.08.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
Revenue per Share: $0.01
GF Value™: $0.08 vs. price of $0.24 (202.8% above fair value)
Industry Position: 99.7% below the Medical Devices & Instruments median (#523 of 753)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 
